輸入代號或公司名稱後按 Enter
1799

易威

-0.45 (-1.51%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
29.35117成交張數本益比5.16股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.10-0.13-0.12-5.5%-1.74%-2.30%
2026Q10.16-0.420.208.6%2.89%-7.16%
2025Q4-0.24-0.59-0.30-18.2%-4.35%-10.38%
2025Q30.05-0.520.063.4%0.91%-9.21%
2025Q2-0.39-0.62-0.49-44.8%-7.05%-11.05%
2025Q1-0.01-0.41-0.01-0.4%-0.09%-6.69%
2024Q4-0.17-0.81-0.21-13.6%-2.88%-14.64%
2024Q3-0.05-1.04-0.07-3.4%-0.89%-17.63%
2024Q2-0.18-1.23-0.22-17.8%-2.93%-20.13%
2024Q1-0.41-1.26-0.48-65.6%-7.04%-19.99%
2023Q4-0.40-1.27-0.44-45.6%-7.06%-21.43%
2023Q3-0.24-1.26-0.27-39.8%-4.15%-20.43%
2023Q2-0.21-1.48-0.25-35.6%-3.65%-19.75%
2023Q1-0.42-1.50-0.49-131.8%-6.83%-20.73%
2022Q4-0.39-1.39-0.46-68.4%-5.98%-19.97%
2022Q3-0.45-1.26-0.26-61.3%-3.24%-18.59%
2022Q2-0.23-1.12-0.37-106.9%-4.57%-20.73%
2022Q1-0.32-659.8%-1.35-0.52-148.8%-6.12%-26.96%
2021Q4-0.27-0.98-0.44-117.5%-4.86%-19.07%
2021Q3-0.32-0.84-0.50-120.0%-5.34%-15.53%
2021Q2-0.45-0.90-0.61-132.1%-7.32%-14.87%
2021Q10.06-0.870.057.1%0.72%-18.26%
2020Q4-0.13-1.28-0.21-23.6%-2.88%-25.11%
2020Q3-0.37-1.94-0.53-150.3%-7.05%-35.93%
2020Q2-0.42-2.03-0.54-80.1%-7.71%-33.18%
2020Q1-0.36-2.21-0.46-58.8%-6.99%-36.64%
2019Q4-0.79-2.45-0.91-103.2%-13.88%-38.99%
2019Q3-0.46-2.57-0.52-64.4%-7.79%-37.70%
2019Q2-0.60-2.45-0.66-61.7%-9.16%-33.32%
2019Q1-0.59-2.48-0.63-74.7%-8.48%-30.45%
2018Q4-0.92-2.42-0.92-61.7%-12.03%-29.00%
2018Q3-0.34-2.37-0.34-36.2%-4.16%-28.89%
2018Q2-0.63-2.93-0.63-74.7%-7.23%-31.97%
2018Q1-0.53-3.06-0.54-58.3%-5.84%-30.41%
2017Q4-0.87-3.45-0.76-104.8%-8.89%-31.65%
2017Q3-0.90-4.16-0.76-77.8%-9.47%-43.41%
2017Q2-0.76-4.14-0.65-60.3%-7.49%-37.55%
2017Q1-0.93-4.15-0.75-77.3%-8.36%-33.77%
2016Q4-1.58-3.79-1.07-101.3%-13.26%
2016Q3-0.87-0.59-45.3%-7.82%